hrp0095p1-337 | Multisystem Endocrine Disorders | ESPE2022

Alopecia totalis at the onset of polyglandular syndrome type 1

Vasiliu Ioana , Trandafir Laura-Mihaela , Preda Cristina , Frasinariu Otilia-Elena , Streanga Violeta , Vasilache Anastasia , Chelaru Nicoleta

Background: The decreased immune tolerance caused by mutations of the autoimmune regulatory gene (AIRE) lead to a spectrum of variable organ specific autoimmune disorders known as autoimmune polyglandular syndrome type 1 (APS-1). The rarity of the syndrome and the heterogenous clinical manifestations at the onset of the disease may delay the diagnosis. Only when two major components of the triad chronic mucocutaneous candidiasis – hypoparathyroidism &nda...

hrp0098p3-41 | Bone, Growth Plate and Mineral Metabolism | ESPE2024

New treatment perspectives in hypophosphatasia

Vasiliu Ioana , Frasinariu Otilia-Elena , Bizim Delia , Chelaru Nicoleta , Armasu Ioana , Trandafir Laura-Mihaela

Introduction: Hypophosphatasia (HPP) is a rare, potentially fatal, either autosomal dominant or recessive genetic disorder caused by the loss of function of the tissue-non-specific isoenzyme of the serum alkaline phosphatase, due to pathogenic variants of the ALPL gene. The onset of the deleterious effects on bone metabolism is highly variable, ranging from mild cases with dental abnormalities to severe forms that can be life-threatening in infancy or early ch...